Literature DB >> 23280048

Intravitreal ranibizumab for diabetic macular oedema: 1-year experiences in a clinical setting.

Troels Brynskov, Caroline Schmidt Laugesen, Torben Lykke Sørensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23280048     DOI： 10.1111/aos.12014

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  6 in total

1.  Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study).

Authors:  Elisabeth Van Aken; Mérédis Favreau; Eva Ramboer; Kris Denhaerynck; Karen MacDonald; Ivo Abraham; Heidi Brié
Journal:  Clin Ophthalmol       Date:  2020-12-02

2.  Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema.

Authors:  Raffael Liegl; Julian Langer; Florian Seidensticker; Lukas Reznicek; Christos Haritoglou; Michael W Ulbig; Aljoscha S Neubauer; Anselm Kampik; Marcus Kernt
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

3.  3-year-data of combined navigated laser photocoagulation (Navilas) and intravitreal ranibizumab compared to ranibizumab monotherapy in DME patients.

Authors:  Tina Rike Herold; Julian Langer; Efstathios Vounotrypidis; Marcus Kernt; Raffael Liegl; Siegfried G Priglinger
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

4.  Efficacy of One-Year Treatment with Aflibercept for Diabetic Macular Edema with Practical Protocol.

Authors:  Tomomi Kaiho; Toshiyuki Oshitari; Tomoaki Tatsumi; Yoko Takatsuna; Miyuki Arai; Norihiro Shimizu; Eiju Sato; Takayuki Baba; Shuichi Yamamoto
Journal:  Biomed Res Int       Date:  2017-12-04       Impact factor: 3.411

Review 5.  Diabetic macular edema: Evidence-based management.

Authors:  David J Browning; Michael W Stewart; Chong Lee
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

6.  The real life data of ranibizumab use among the diabetic macular edema patients in Turkey: Documenting the improvement with clinical optimization during three consecutive years.

Authors:  Abdullah Ozkaya; Mehmet Ozveren; Ali Demircan
Journal:  Saudi J Ophthalmol       Date:  2018-04-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.